Quarterly ResultMay 7, 2026, 04:08 PM
SkinHealth Systems Q1 Net Sales $64.9M; Lowers FY26 Revenue Outlook
AI Summary
SkinHealth Systems reported Q1 2026 net sales of $64.9 million, a 6.7% decrease year-over-year, but significantly outperformed on adjusted EBITDA, which rose to $8.5 million. The company improved its net loss to $(6.6) million and expanded adjusted gross and EBITDA margins. However, SkinHealth Systems lowered its full-year 2026 revenue outlook to $280-$295 million, reflecting continued pressure on device sales in a challenging market.
Key Highlights
- Q1 2026 net sales decreased 6.7% to $64.9 million from $69.6 million in Q1 2025.
- Adjusted EBITDA increased to $8.5 million in Q1 2026 from $7.3 million in Q1 2025.
- Net loss improved to $(6.6) million in Q1 2026 from $(10.1) million in Q1 2025.
- Full-year 2026 net sales guidance lowered to $280-$295 million.
- Q1 2026 adjusted gross margin was 72.2%, up from 71.9% in Q1 2025.
- Active install base grew to 36,419 systems from 35,014 in Q1 2025.
- Americas net sales were $44.6 million, APAC $6.6 million, and EMEA $13.7 million.
- 746 delivery systems were sold in Q1 2026, down from 862 in Q1 2025.